Live Price
Live Volume
Chart Volume 0
Volume 0
5 secProtagonist Therapeutics, Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $144.85 |
|---|---|
| Close | $144.85 |
| Low | $144.85 |
| Low Change | 0.00 (0.00%) |
| High | $144.85 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 119.334K |
| Dollar Volume | $17.29M |
Regular Trading Hours Yesterday
+0.62(+0.43%)
| Open | $144.34 |
|---|---|
| Close | $144.96 |
| Low | $142.54 |
| Low Change | -1.80 (-1.25%) |
| High | $146.00 |
| High Change | +1.66 (+1.15%) |
| Range | $3.46 |
| Volume | 177.29K |
| Dollar Volume | $25.70M |
Premarket Yesterday
+0.17(+0.12%)
| Open | $144.34 |
|---|---|
| Close | $144.51 |
| Low | $143.34 |
| Low Change | -1.00 (-0.69%) |
| High | $144.51 |
| High Change | +0.17 (+0.12%) |
| Range | $1.17 |
| Volume | 3.451K |
| Dollar Volume | $498.70K |
Protagonist Therapeutics, News
There is no current news for this stock at the moment.
Protagonist Therapeutics, Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Protagonist Therapeutics, Moving Averages
| 5 Day Moving Average (SMA5) | $142.56 |
|---|---|
| 10 Day Moving Average (SMA10) | $140.14 |
| 20 Day Moving Average (SMA20) | $139.55 |
| 50 Day Moving Average (SMA50) | $142.94 |
| 100 Day Moving Average (SMA100) | $138.09 |
| 200 Day Moving Average (SMA200) | $116.63 |
Protagonist Therapeutics, Statistics
| Average Volume (30 Days) | 727.62K |
|---|---|
| P/E Ratio (Current) | 112.29 |
| EPS (Current) | $1.28 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 11.30 |
| Current Ratio | 21.71 |
| Quick Ratio | 21.71 |
| Debt to Equity | 0.00 |
| Enterprise Value | $8.88B |
| EV to EBITDA | 149.29 |
| EV to Sales | 31.49 |
| Price to Book | 11.05 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 32.98 |
| Return on Assets | 0.09% |
| Return on Equity | 0.10% |
Protagonist Therapeutics, Stock Splits
There have been no stock splits for Protagonist Therapeutics, (PTGX).
Protagonist Therapeutics, Dividends
There have been no dividends for Protagonist Therapeutics, (PTGX).